Medullary thyroid carcinoma in Northern Ireland,1967-1997

Annals of the Royal College of Surgeons of England

Volumn 82, Issue 3, 2000, Pages 156-161

  Dolan, S J ^a   Russell, C F J ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

Medullary thyroid carcinoma; Multiple endocrine neoplasia type 2; Non MEN familial medullary thyroid carcinoma; Total thyroidectomy

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; GENETIC SCREENING; HUMAN; MALE; MULTIPLE ENDOCRINE NEOPLASIA; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY;

ADOLESCENT; ADULT; CARCINOMA, MEDULLARY; FEMALE; FOLLOW-UP STUDIES; GENETIC SCREENING; HUMANS; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B; SURVIVAL RATE; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 0034071157     PISSN: 00358843     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Dunn JM, Farndon JR. Medullary thyroid carcinoma. Br J Surg 1993; 80: 6-9.
2. Bergholm U, Adami HO, Telenius-Berg M, Johaansson H, Wilander E. Incidence of sporadic and familial medullary thyroid cancer in Sweden from 1959 through 1981: a nationwide study in 126 patients. Swedish MCT Study Group. Acta Oncol 1990; 29: 9-15.
3. Hazard JB, Hawk WA, Crile G. Medullary (solid) carcinoma of the thyroid: a clinicopathologic entity. J Clin Endocrinol Metab 1959; 19: 152-61.
4. Russell CF, van Heerden JA, Sizemore GW, Adis AJ, Taylor WF, Remine WH et al. The surgical management of medullary thyroid carcinoma. Ann Surg 1983; 197: 42-8.
5. Farndon JR, Leight GS, Dilley WG, Baylin SB, Smallridge RC, Harrison TS et al. Familial medullary thyroid carcinoma without associated endocrinopathies: a distinct clinical entity. Br J Surg 1986; 73: 278-81.
6. Carlson K, Dou S, Chi D, Scavarda N, Toshima K, Jachson CE et al. Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. Proc Natl Acad Sci USA 1994; 91: 1579-83.
7. Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC et al. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 1993; 2: 851-6.
8. Russell CFJ. Medullary carcinoma of the thyroid gland. Ulster Med J 1980; 49: 54-64.
9. Hadden DR, O'Reilly F, Kennedy L, Russell C. Multiple endocrine neoplasia type 2A: a Northern Ireland and Australian family. Henry Ford Hosp Med J 1987; 35: 107-9.
10. Wells Jr SA, Baylin SB, Leight GS et al. The importance of early diagnosis in patients with hereditary medullary thyroid carcinoma. Ann Surg 1982; 195: 595-9.
11. Bergholm U, Adami HO, Bergstrom R, Backdahl M, Akerstrom G. Long-term survival in sporadic and familial medullary thyroid carcinoma with special reference to clinical characteristics as prognostic factors. The Swedish MTC Study Group. Acta Chir Scand 1990; 156: 37-46.
12. Kallinowski F, Buhr HJ, Meybier H, Eberhardt M, Herfarth C. Medullary carcinoma of the thyroid-therapeutic strategy derived from fifteen years experience. Surgery 1993; 114: 491-6.
13. Gharib H, McConahey WM, Tiegs RD, Bergstralh EJ, Goellner JR, Grant CS et al. Medullary thyroid carcinoma: clinicopathologic features and long term follow-up of 65 patients treated during 1946 through 1970. Mayo Clin Proc 1992; 67: 934-40.
14. Wells Jr SA, Baylin SB, Gann DS. Medullary thyroid carcinoma: relationship of method of diagnosis to pathologic staging. Ann Surg 1978; 188: 377-83.
15. Moley JF. Medullary thyroid cancer. Surg Clin North Am 1995; 75: 405-20.
16. Wells SA, Chi D, Toshima K, Dehner LP, Coffin CM, Dowton SB et al. Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A. Ann Surg 1994; 220: 237-50.
17. O'Riordain DS, O'Brien T, Weaver AL, Gharib H, Hay ID, Grant CS et al. Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B. Surgery 1994; 116: 1017-23.
18. Telander RL, Zimmerman D, van Heerden JA, Sizemore GW. Results of early thyroidectomy for medullary thyroid carcinoma in children with multiple endocrine neoplasia type 2. J Pediatr Surg 1986; 21: 1190-4.
19. Moley JF, Wells SA, Dilley WG, Tisell LE. Reoperation for recurrent or persistent medullary thyroid cancer. Surgery 1993; 114: 1090-6.
20. Ellenhorn JDI, Shah JP, Brennan MF. Impact of therapeutic regional lymph node dissection for medullary carcinoma of the thyroid gland. Surgery 1993; 114: 1078-82.
21. Tisell LE, Hansson G, Jansson S, Salander H. Reoperation in the treatment of asymptomatic metastasizing medullary thyroid carcinoma. Surgery 1986; 99: 60-6.
22. Van Heerden JA, Grant CS, Gharib H, Hay ID, Ilstrup DM. Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma. Ann Surg 1990; 212: 395-400.